Results 71 to 80 of about 676,672 (336)

Gut alterations in a chronic kidney disease rat model with diet‐induced vascular calcification

open access: yesFEBS Open Bio, EarlyView.
Chronic kidney disease (CKD) patients often suffer from intestinal and/or mineral and bone disorders. Using a rat model, we showed that uremic vascular calcification is associated with gut barrier alterations (decreased gut mucus production and Nlrp6 gene expression, increased gut inflammation), and plasma retention of gut‐origin uremic toxins (indoxyl
Piotr Bartochowski   +13 more
wiley   +1 more source

Antifungal Potency of Secondary Metabolites Produced by Endophytic Bacteria against Pathogenic Fungi Pyricularia oryzae Cav.

open access: yesJurnal Perlindungan Tanaman Indonesia, 2019
Blast disease caused by Pyricularia oryzae Cav. is one of the most important diseases on rice. One of the alternative controlling methods in P. oryzae is biological control through the utilization of secondary metabolites produced by endophytic bacteria.
Fitri Widiantini   +3 more
doaj   +1 more source

Insecticidal Activity of Plant Secondary Metabolites

open access: yesPlants, 2022
Plant-insect interactions are one of the most fascinating fields of research attracting biologists, entomologists, botanists, as well as a wide range of multidisciplinary researchers [...]
Giovanni Benelli, Filippo Maggi
doaj   +1 more source

Secondary Metabolites and Nutrient Balance in Casuarinas: an Insight Into Protein Competition Model (PCM) [PDF]

open access: yes, 2014
The total phenolics, total condensed tannins (TCT), nitrogen (N) and total protein (TP) in needles of Casuarina equisetifolia and Casuarina junghuhniana were studied to understand the carbon-nutrient balance (CNB) and the growth-differentiation balance ...
Babu, D. S. (Devaraj)   +2 more
core  

Evolution of secondary metabolites in legumes (Fabaceae) [PDF]

open access: yes, 2013
Legumes produce a high diversity of secondary metabolites which serve as defence compounds against herbivores and microbes, but also as signal compounds to attract pollinating and fruit-dispersing animals.
Wink, M.
core   +1 more source

GDP‐fucose transporter SLC35C1: a potential regulatory role in cytosolic GDP‐fucose and fucosylated glycan synthesis

open access: yesFEBS Open Bio, EarlyView.
The inactivation of SLC35C1 (GDP‐fucose transporter) and enzymes involved in GDP‐fucose biosynthesis was studied. Fucose supplementation increases the level of GDP‐fucose to abnormal, millimolar values in the absence of the TSTA3 protein and SLC35C1 in contrast to the GMDS/SLC35C1 double mutant.
Edyta Skurska, Mariusz Olczak
wiley   +1 more source

Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes

open access: yesАнтибиотики и Химиотерапия, 2020
Review represents data on new active metabolites isolated from marine actinomycetes published in 2007 to 2014. Marine actinomycetes are an unlimited source of novel secondary metabolites with various biological activities.Among them there are antibiotics,
T. I. Orlova   +2 more
doaj  

Diversity of secondary metabolites from Genus Artocarpus (Moraceae) [PDF]

open access: yes, 2010
Abstrak. Hakim A. 2010. Keanekaragaman metabolit sekunder Genus Artocarpus (Moraceae). Nusantara Bioscience 2:146-156. Beberapa spesies dari genus Artocarpus (Moraceae) telah diteliti kandungan bahan alamnya.
HAKIM, ALIEFMAN
core   +3 more sources

Cloning and characterization of novel methylsalicylic acid synthase gene involved in the biosynthesis of isoasperlactone and asperlactone in Aspergillus westerdijkiae [PDF]

open access: yes, 2009
Aspergillus westerdijkiae is the main producer of several biologically active polyketide metabolites including isoasperlactone and asperlactone. A 5298 bp polyketide synthase gene ‘‘aomsas” has been cloned in Aspergillus westerdijkiae by using gene ...
Atoui, Ali   +8 more
core   +1 more source

Metabolic Consequences of Rheumatoid Arthritis

open access: yesArthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy